CBU
PRVA icon

CIBC Bancorp USA’s Privia Health PRVA Stock Holding History

CIBC Bancorp USA’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$305K Buy
+12,263
New +$264K ﹤0.01% 1077

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Bancorp USA's PRVA Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Privia Health (PRVA) in Q3 2025: 12,263 shares worth $305K. The stake represents ﹤0.01% of the portfolio and ranks #1077 among its holdings.

259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • CIBC Bancorp USA held 12,263 shares of Privia Health worth $305K as of Q3 2025.
  • Privia Health was a new CIBC Bancorp USA position in Q3 2025.
  • Privia Health made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1077 holding.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.